Part 3: Medication-Related NEEDS: What Black persons with CKD say they need from health care practitioners and health system
Summary
As discussed in Part 1 and Part 2, there is a disproportionate impact of CKD on Black persons. Individuals need to have CKD identified and diagnosed as early as possible in the disease process to attain desired health outcomes. This successful management of CKD and its complications requires an awareness and understanding of the diagnosis. Without awareness, patients are unlikely to become informed and adequately participate in their care and become motivated to adopt healthy behaviors.
Objectives
- Develop strategies for screening Black persons at high risk for CKD with serum creatinine (eGFR) and urine albumin to creatinine ratio
- Focus on pharmacoequity when creating a medication-related plan
- Identify key medication-related facts and medication alternatives that Black patients with CKD want to know
- Apply successful practitioner strategies to improve pharmacoequity
The following planners and presenters have disclosed a financial relationship with an ineligible company:
- Kenrik (Obidiugwa) Duru, MD, MS - Consultant, ExactCare Pharmacy
- Stephen Z. Fadem, M.D., FACP, FASN - Clinical Research, Joint Venture member, Ardelyx, Reata, DaVita
- Calvin Meaney, PharmD, BCPS - Speaker's Bureau [GSK], Consultant [GSK, Wolters-Kluwer (Lexicorp)]
- Wendy St. Peter, FCCP, FASN, FNKF - Consultant [GSK]
There are no conflicts of interest or financial relationships with an ineligible company that have been disclosed by the rest of the planners and presenters of this learning activity.
All relevant financial relationships have been mitigated.
In support of improving patient care, this activity is planned and implemented by The National Center for Interprofessional Practice and Education Office of Interprofessional Continuing Professional Development (OICPD). The OICPD is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians: The National Center for Interprofessional Practice and Education designates this live activity for .75 hours AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with their participation.
Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
Nurses: Participants will be awarded .75 contact hours of credit for attendance in this module.
Nurse Practitioners: The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Pharmacists: This activity is approved for .75 contact hours. UAN: JA4008105-9999-23-047-H01-P.
IPCE: This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credits for learning and change.
